Adicet Bio, Inc. (ACET) — Financial statements
Income statement, balance sheet, and cash flow for Adicet Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00↓100.0% | 25↑156.8% | 10 | |
| Cost of Revenue | 6 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -6 | 0.00 | 0.00↓100.0% | 25↑156.8% | 10 | |
| Operating Expenses | ||||||
| R&D Expenses | 99↓0.2% | 99↓6.3% | 106↑48.8% | 71↑45.6% | 49 | |
| General & Administrative Expenses | 23↓18.8% | 28↑6.6% | 27↑0.9% | 26↑18.3% | 22 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 23↓18.8% | 28↑6.6% | 27↑0.9% | 26↑18.3% | 22 | |
| Other Expenses | -6 | 0.00↓100.0% | 19 | 0.00 | 0.00 | |
| Operating Expenses | 116↓9.3% | 128↓16.1% | 152↑55.9% | 98↑37.1% | 71 | |
| Total Costs & Expenses | 122↓4.3% | 128↓16.1% | 152↑55.9% | 98↑37.1% | 71 | |
| Operating Results | ||||||
| Operating Income | -122↑4.3% | -128↑16.1% | -152↓109.6% | -73↓18.1% | -61 | |
| Depreciation & Amortization | 6↓1.3% | 6↑6.1% | 6↑21.7% | 5↑225.7% | 2 | |
| EBITDA | -116↓4.6% | -111↑19.0% | -137↓111.0% | -65↓7.1% | -60 | |
| EBIT | -122↓4.3% | -117↑17.9% | -143↓104.6% | -70↓12.5% | -62 | |
| Interest & Other Income | ||||||
| Net Interest Income | 6↓46.4% | 11↑7.6% | 10↑170.5% | 4↑4429.4% | -0.09 | |
| Interest Income | 6↓46.1% | 11↑7.6% | 10↑164.7% | 4↑4031.9% | 0.09 | |
| Interest Expense | 0.04↑800.0% | 0.00 | 0.00↓100.0% | 0.08↓54.5% | 0.18 | |
| Non-Operating Income | 0.00↑100.0% | -10↓11.6% | -9↓231.0% | -3↓651.7% | 0.52 | |
| Other Income / Expenses | 5↓49.4% | 10↑11.9% | 9↑239.7% | 3↑499.6% | -0.69 | |
| Income Before Tax | -117↑0.3% | -117↑17.9% | -143↓104.4% | -70↓12.3% | -62 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.13 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -117↑0.3% | -117↑17.9% | -143↓104.4% | -70↓12.6% | -62 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -117↑0.3% | -117↑17.9% | -143↓104.4% | -70↓12.6% | -62 | |
| Bottom-Line Net Income | -117↑0.3% | -117↑17.9% | -143↓104.4% | -70↓12.6% | -62 | |
| EPS (Basic) | -16.95↑20.3% | -21.28↑59.8% | -52.96↓94.7% | -27.20↑15.0% | -32.00 | |
| EPS (Diluted) | -16.95↑20.3% | -21.28↑59.8% | -52.96↓94.7% | -27.20↑15.0% | -32.00 | |
| Weighted Average Shares | 7↑25.5% | 5↑104.1% | 3↑4.8% | 3↑32.7% | 2 | |
| Weighted Average Diluted Shares | 7↑25.5% | 5↑104.1% | 3↑4.8% | 3↑32.7% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.